ArticleCureus2022

Successful Discontinuation of Eculizumab in a Pediatric Patient With Atypical Hemolytic Uremic Syndrome and Underlying Systematic Lupus Erythematosus.

Issa Alhamoud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.